Fundraising Fox
Seed–Series B · 11 people tracked
Find your way into Tenmile
Sign up to see every warm intro you have to Tenmile
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tenmile team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Tenmile invests in teams addressing major unmet needs in human health, backing bold ideas with capital, expertise, and conviction to produce better health outcomes alongside strong commercial returns. The firm seeks to make Australia a global health leader by helping translate scientific breakthroughs into scalable, global solutions, bridging the gap between breakthrough research and global impact. Its team combines sector knowledge across medicine, academia, tech transfer, pharma, biotech, and investment banking to support founders. Tenmile invests from seed and beyond across six current focus areas, positioning itself as a founder-first, impact-driven partner offering more than capital.
Source: firm website, verified Aug 3, 2026.
Team · 11 people
from the firm's website
Founder mafia
3 people who came through Tenmile went on to found or lead other companies.
What they invest in
from 28 of 37 portfolio companiesBiotech ×21Healthtech ×16Medical Devices ×15Digital Health ×12AI & Machine Learning ×11Deep Tech ×9Mental Health ×3Consumer ×2
HQs:Australia×10United States×6
Who they back
founder profiles across 12 portfolio companiesFounding team size:solo founder×32 founders×83 founders×1
Where their founders studiedfrom 15 founders with education data
Princeton University ×3Monash University ×2The University of Texas at Austin ×2University of Sydney ×2UNSW ×2
What their founders studiedfrom 14 founders with field-of-study data
Life Sciences ×7Business & Management ×2Computer Science ×2Economics ×2
Accelerator rootsportfolio companies that came through a program
Investments · 37 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 42023 · 12022 · 28 dated
Aravax is a clinical-stage biotechnology company developing next-generation immunotherapies to treat food allergies.
BiotechHealthtechMedical DevicesMelbourne, AU
Sara Prickett(Co-founder)in
Co-investorsBreakthrough VictoriaNovartis Venture FundUniSeed Pty Ltd.
Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs.
BiotechDeep TechHealthtechMedical Devices
Ryan Cirz(Co-founder & CEO)inAndrew McCandlish(Co-founder & COO)inPeter Smith(Chief Scientific Officer)inDaniel Cloutier(VP, Development)in
Co-investorsNovo Holdings
AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.
BiotechHealthtechMedical DevicesCambridge, US
Andrew Adamovich(Director)inPhilina Lee(Executive Officer, Director)inAaron Pickett(Executive Officer)in
BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)
Co-investorsBain Capital Life SciencesCatalio Capital Management, LPProto AxiomSanofi VenturesSV Health InvestorsAbingworth+2 more
Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.
Biotech
Co-investorsBooster Innovation FundCure Kids VenturesBrandon Capital Partners
Antares Therapeutics discovers and develops precision medicines, with a focus on small molecule therapies targeting previously undruggable oncology targets and other serious diseases.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Adam Friedman(Chief Executive Officer)inAndrew Fedder(Executive Officer, Director)inBrian Piper(Executive Officer, Director)in
Co-investorsAtlas VentureLightspeed Venture PartnersVida VenturesOmega FundsAbingworthAlleyCorp+1 more
AusBiotech is the national industry association representing Australia's life sciences ecosystem, advocating for policy, facilitating connections, and supporting growth for biotechnology, medical technologies, and digital health companies.
BiotechDigital HealthMedical DevicesBrisbane, AU
Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system.
BiotechDigital HealthHealthtechMedical DevicesAdelaide, AU
Simon Barry(Chief Medical Scientist)inDr Deborah Rathjen(Chief Executive Officer & Managing Director)Professor Shaun McColl(Chief Scientific Officer)
BoardClaudine Bonder(Head, Vascular Biology and Cell Trafficking Laboratory)
Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides.
AI & Machine LearningBiotechDeep Tech
Matthew Levy(Co-founder)in
Co-investorsLux CapitalDCVC Bio
Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.
AI & Machine LearningBiotechDeep Tech
Co-investorsBioBritDCVC (Data Collective)DCVC BioAlexandriaCasdin CapitalLux Capital
CurveBeam AI develops point-of-care cone beam CT imaging systems combined with AI and deep learning tools for orthopedic and bone health applications, including fragility fracture prevention.
AI & Machine LearningBiotechHardwareHealthtechMedical DevicesHatfield, US
BoardGregory Brown(Director)David Seeman(Director)Waradana Malitha Hashan De Silva(Director)Robert Lilley(Director)
Co-investorskineo finance
Clinical services company collecting patient data and developing novel drug and care models, including MDMA-assisted treatment for PTSD.
Humanitix operates a non-profit ticketing platform for event hosts and attendees, transforming booking fees into charitable donations for education, healthcare, and social causes worldwide.
ConsumerImpact & Social GoodMarketplacesSaaSSocialPhiladelphia, US
Adam McCurdie(Co-founder)inJoshua Ross(Co-founder)Josh(Co-founder)
Inventia Life Science provides RASTRUM Workflow Paths, tools for generating reproducible 3D cell models for research and drug discovery.
AI & Machine LearningBiotechDeep TechMedical Devices
Co-investorsAirTree VenturesIn-Q-TelMain Sequence VenturesVU Venture PartnersBlackbird VenturesSkip Capital
Kantoko operates a telehealth platform connecting adults with ADHD specialists for remote diagnosis and treatment planning in Australia.
Digital HealthHealthtechMental HealthAustralia, AU
Co-investorsSide Stage Ventures
LimmaTech develops vaccine technologies and programs designed to combat antimicrobial-resistant pathogens and prevent severe infections.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsAdjuvant CapitalAndera PartnersNovo Holdings
Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Doug Ward(CEO)inPaul Kase(Chief Commercial Officer)in
BoardSam Lanyon(Non-Executive Chair)
Mindset is a daily wellness and self-care app featuring audio collections and stories from celebrities and experts.
ConsumerMental HealthWellness & FitnessKing Of Prussia, US
April J Perrymore(Executive Officer, Director, Promoter)Darlene Link(Executive Officer, Director, Promoter)
Co-investorsA.Capital Venturesalphabet angelsTq Ventures LlcUnion Square Ventures (USV)Banana CapitalGold House Ventures+3 more
Mindset Health develops digital health programs using hypnotherapy and mind-body medicine to help patients manage gastrointestinal disorders and improve health outcomes.
Digital HealthHealthtechMedical DevicesMental HealthWellness & FitnessMelbourne, AU
Alex Naoumidis(Co-founder \u0026 Co-CEO)inChris Naoumidis(Founder)inDan Borthwick(CTO)Pavi I(Head of People \u0026 Talent)
Co-investorsAlberts Impact VenturesAlumni VenturesFifty YearsKing River CapitalPerennial PartnersY Combinator+14 more
Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.
AI & Machine LearningBiotechDeep Tech
Atray Dixit(Co-founder, CEO)inBill Grossman(Co-founder, Strategic Advisor)in
Co-investorsAdverb VenturesIllumina Ventures
Perx develops a digital health platform that uses engagement and behavioral incentive techniques to help older patients, those with chronic conditions, and underserved populations adhere to their treatment plans and manage their health.
Digital HealthHealthtechSaaSAustralia / USA
Hugo Rourke(CEO & Co-founder)inScott(COO & Co-founder)
Co-investorsAirTree VenturesTractor VenturesWildwood VenturesGiant Leap
SpeeDx provides multiplexing technology platforms and diagnostic assays for detecting infectious disease pathogens, including customized solutions for respiratory infections, sexually transmitted infections, gastrointestinal illness, and antimicrobial resistance markers.
BiotechMedical Devices
Proton Intelligence develops CKM™, a continuous monitoring medical device drawing on biosensing and minimally invasive microdevice technology for clinical use.
Deep TechDigital HealthHealthtechMedical Devices
Co-investors15th RockAIN VenturesLongeVCSOSV
Proxima Bio is an early-stage biotechnology company developing protein degradation technology to target previously undruggable proteins for treatment of autoimmune conditions and cancers.
BiotechHealthtechMedical DevicesMelbourne, AU
Jase(Co-founder)Jon(Co-founder)John McFarland(Executive Officer)Zachary Carpenter(Executive Officer, Director)
BoardJason Pontin(Director)inAlex Gasner(Director)
Co-investorsTin Alley VenturesDCVC (Data Collective)
Halle Tecco(Founder)Bill Evans(Founder)in
Co-investorsFlare Capital PartnersKaiser Permanente VenturesNew Enterprise Associates (NEA)Rock Health CapitalSteelSky VenturesStorm Ventures
SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions.
BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesSydney, AU
Alison Todd(Co-founder)Elisa Mokany(Co-founder)in
Co-investorsNorthpond Ventures
Sweetch provides AI-driven personalized behavioral interventions that help patients manage chronic conditions through continuous engagement and adaptive recommendations.
AI & Machine LearningDigital HealthHealthtech
Co-investorsEntrée CapitalLionBirdPontifax Venture CapitalTal VenturesOurCrowd
Syndeio Biosciences is a synapse-focused biotech developing precision neurotherapeutics for neuropsychiatric, mental health, and cognitive disorders such as depression and Alzheimer's.
AI & Machine LearningBiotechDigital Health
Co-investorsEvolution VC PartnersPalo Santo VCCatalio Capital Management
A venture capital firm that invests in the commercialization of research, with a focus on innovations emerging from the University of Melbourne and its affiliated medical research institutions and hospitals in the Melbourne Biomedical Precinct.
BiotechDeep TechImpact & Social GoodMelbourne, AU
Co-investorsBreakthrough VictoriaAGI HOUSE VENTURESAramco VenturesBTECH CONSORTIUMEJF VenturesLakestar+1 more
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US
Alice Zhang(CEO)inJason Chen(Founder)inEmily Ripka(Vice President Product \u0026 Engineering)inNaveen Jain(Investor)inGeorge Spencer(Operations)
Co-investorsAgent CapitalALS Investment FundBOLD LongevityDraper AssociatesFitz Gate VenturesGreat Oaks Venture Capital+28 more
Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches.
BiotechDeep TechDigital HealthHealthtechSydney, AU
Joshua Ismin(Co-founder, President)inDr. Sam Banister(Co-founder, Chief Scientific Officer)
Co-investorsPalo Santo VCRadar VenturesXEIA Venture PartnersCapitalTCommon MagicSure Valley Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CuttlefishCuttlefish BioRekover TherapeuticsSyndeioYosemite
Exits · 1
1 acquisitionsLimmaTech Biologicsacq. by Lilly
Portfolio news
latest coverage across their companies
AdvanCell Isotopes · intelligence360.news · Aug 4, 2026
Emyria · emyria.com · Jul 28, 2025
Antares Therapeutics · finsmes.com · Jun 11, 2025
Humanitix · help.humanitix.com · Apr 23, 2025
Frequently asked questions
- How many investments has Tenmile made?
- Tenmile has 37 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Tenmile invest at?
- Tenmile invests at the Seed, Series A, Series B stages.
- What sectors does Tenmile focus on?
- Tenmile focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices, Wellness & Fitness.
- Who does Tenmile co-invest with?
- Tenmile most often shares deals with AirTree Ventures, Booster Innovation Fund, Breakthrough Victoria, among 66 tracked co-investors.
Similar investors
Portfolia operates thematic venture funds designed by and for women investors, backing companies in women's health, active aging, and longevity, alongside a community of over 2,200 women investors across 48 states and 20 countries.
CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.
AgeTech Capital is a purpose-driven private market investment firm backing affordable technology solutions that support healthier, wealthier and more fulfilling aging.
JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.